Cargando…
Lysophosphatidic acid (LPA)-antibody (504B3) engagement detected by interferometry identifies off-target binding
BACKGROUND: Lysophosphatidic acid (LPA) is a bioactive lysophospholipid that acts through its six cognate G protein-coupled receptors. As a family, lysophospholipids have already produced medicines (e.g., sphingosine 1-phosphate) as is being pursued for LPA through the use of specific antibodies tha...
Autores principales: | Ray, Manisha, Kihara, Yasuyuki, Bornhop, Darryl J., Chun, Jerold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048308/ https://www.ncbi.nlm.nih.gov/pubmed/33853612 http://dx.doi.org/10.1186/s12944-021-01454-4 |
Ejemplares similares
-
Unlabeled lysophosphatidic acid receptor binding in free solution as determined by a compensated interferometric reader
por: Ray, Manisha, et al.
Publicado: (2020) -
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008) -
Novel Antagonist
of the Type 2 Lysophosphatidic Acid
Receptor (LPA(2)), UCM-14216, Ameliorates Spinal Cord Injury
in Mice
por: Khiar-Fernández, Nora, et al.
Publicado: (2022) -
Phosphorylation and Internalization of Lysophosphatidic Acid Receptors LPA(1), LPA(2), and LPA(3)
por: Alcántara-Hernández, Rocío, et al.
Publicado: (2015) -
Dual Role of Lysophosphatidic Acid Receptor 2 (LPA(2)) in Amyotrophic Lateral Sclerosis
por: Puigdomenech-Poch, Maria, et al.
Publicado: (2021)